SCHEMBL7017394

SCHEMBL7017394

c1cc(C2CCC3CCCCN32)ccc1OCCCC1CCCNC1

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.44
NPY1R P25929 15/20 0.40
KCNH2 Q12809 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4294141 1.00 HRH3 (0.44) HRH3NPY1RKCNH2CYP3A4CYP2C9
SCHEMBL4438033 1.00 HRH3 (0.44) HRH3NPY1RKCNH2CYP3A4CYP2C9
SCHEMBL4431773 1.00 HRH3 (0.44) HRH3NPY1RKCNH2CYP3A4CYP2C9
SCHEMBL6701200 1.00 HRH3 (0.44) HRH3NPY1RKCNH2CYP3A4CYP2C9
SCHEMBL4295487 0.93 NPY1R (0.40) HRH3NPY1R
SCHEMBL4288167 0.82 HRH3 (0.40) HRH3
SCHEMBL4288176 0.82 HRH3 (0.40) HRH3
SCHEMBL4288170 0.82 HRH3 (0.40) HRH3
SCHEMBL4294004 0.81 HRH3 (0.39) HRH3NPY1R
SCHEMBL4293999 0.81 HRH3 (0.39) HRH3NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326863-A2 OCTAHYDRO-INDOLIZINES AND QUINOLIZINES AND HEXAHYDRO-PYRROLIZINES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-07-16 EP claimed
WO-2002024695-A2 OCTAHYDRO-INDOLIZINES AND QUINOLIZINES AND HEXAHYDRO-PYRROLIZINES ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2002-03-28 WO claimed
EP-1326863-A2 OCTAHYDRO-INDOLIZINES AND QUINOLIZINES AND HEXAHYDRO-PYRROLIZINES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-07-16 EP disclosed
WO-2002024695-A2 OCTAHYDRO-INDOLIZINES AND QUINOLIZINES AND HEXAHYDRO-PYRROLIZINES ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2002-03-28 WO disclosed